Home
Storia in 8 fonti
Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations with government
The negotiation program was created as part of the 2022 Inflation Reduction Act, which capped years of debate over whether the federal government should be allowed to haggle directly with manufacturers over the prices of drugs in Medicare.
- ·
apnews.com
Supreme Court rejects appeals from drug manufacturers over Medicare price negotiations
The Supreme Court has rejected appeals from pharmaceutical companies that object to negotiating Medicare drug prices with the federal government.
- ·
eu.usatoday.com
Pharma companies want to block Medicare drug discounts. Supreme Court weighs in
Pharmaceutical companies are trying to prevent Medicare from negotiating discounts for drugs. Their legal challenges have been unsuccessful.
